top of page

ACKNOWLEDGEMENTS
The Organizing Committee wishes to acknowledge the following companies whose generous support has made this Conference possible:
SPONSORS
BIAL
Biocodex, France
Eisai Inc., USA
GW Pharmaceuticals PLC, UK
LivaNova Belgium N.V., Belgium
Medtronic, USA
Novartis Farma S.P.A., Italy
Ontario Brain Institute, Canada
Ovid Therapeutics Inc., USA
Pfizer Inc., USA
Proximagen LLC, USA
Sage Therapeutics, Inc, USA
SK Biopharmaceuticals, USA
UCB BioPharma sprl., Belgium
Vitaflo International Ltd, UK
Zogenix Inc., USA
CONTRIBUTORS
BioMarin International Limited, Ireland
Biscayne Pharmaceuticals, Inc., USA
Boehringer Ingelheim Vetmedica GmbH, Germany
Engage Therapeutics
Empatica Inc, USA
Marinus Pharmaceuticals, Inc., USA
Neurelis, USA
NeuroPace, Inc., USA
PIQUR Therapeutics AG, Switzerland
Yissum R&D Company of the Hebrew University of Jerusalem
Xenon Pharmaceuticals Inc.
bottom of page